Additional $22B Authorized for COVID-19 Response
On January 6, the U.S. Department of Health and Human Services (HHS) announced the U.S. Centers for Disease Control and Prevention (CDC) will provide more than $22 billion to states, localities and territories in response to the COVID-19 pandemic.
On January 6, the U.S. Department of Health and Human Services (HHS) announced the U.S. Centers for Disease Control and Prevention (CDC) will provide more than $22 billion to states, localities and territories in response to the COVID-19 pandemic, as directed by the Coronavirus Response and Relief Supplemental Appropriations Act. The funding will provide critical support for testing and vaccination-related activities.
According to HHS, more than $19 billion will be allocated to jurisdictions through the existing CDC Epidemiology and Laboratory Capacity cooperative agreement. These funds will support testing, contact tracing, surveillance, containment, and mitigation to monitor and suppress the spread of COVID-19. Award recipients will include 64 jurisdictions, including all 50 states, the District of Columbia, five major cities, and U.S. territories and islands. Consistent with Congressional direction, funds will be allocated using a population-based formula.
More than $3 billion will be made available in an initial award to jurisdictions through the existing CDC Immunization and Vaccines for Children cooperative agreement. These funds will support a range of COVID-19 immunization activities.
From Decisions in Dentistry. February 2021;7(2):8.
